Description
Balicatib is an inhibitor of cathepsin K that displays anti-resorptive activity. Balicatib inhibits osteoclast activity, decreasing bone turnover and increasing bone mineral density and bone formation rates.
Product Unit Size | Cost | Quantity | Stock |
---|
Balicatib is an inhibitor of cathepsin K that displays anti-resorptive activity. Balicatib inhibits osteoclast activity, decreasing bone turnover and increasing bone mineral density and bone formation rates.
Cas No. | 354813-19-7 |
---|---|
Purity | ≥98% |
Formula | C23H33N5O2 |
Formula Wt. | 411.55 |
IUPAC Name | N-{1-[(Cyanomethyl)carbamoyl]cyclohexyl}-4-(4-propyl-1-piperazinyl)benzamide |
Synonym | AAE-581 |
Solubility | DMSO: ≥ 46 mg/mL |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Jerome C, Missbach M, Gamse R. Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys. Osteoporos Int. 2012 Jan;23(1):339-49. PMID: 21380636.
Chappard D, Libouban H, Mindeholm L, et al. The cathepsin K inhibitor AAE581 induces morphological changes in osteoclasts of treated patients. Microsc Res Tech. 2010 Jul;73(7):726-32. PMID: 20025055.
NSAID; COX-1/2 inhibitor.
Peptide, derivative of AT I, cleavage product o...
Ca2+-sensing receptor agonist.
Endogenous peptide hormone fragment, involved i...
Folic acid derivative
Casein kinase 1 inhibitor.
δ2OR antagonist.
NSAID; COX-1/2 inhibitor.
Derivative of methyl caffeate, hydroxycinnamic ...
Thienylbutyl ITC analog.
Enkephalinase inhibitor.
Endogenous peptide hormone inolved in gastric e...
Ras inhibitor.
ITC, erucin analog.
Diterpene found in Anisomeles.
Semi-synthetic analog of taxol; microtubule dep...
Natriuretic, vasodilatory peptide, bradykinin a...
Peptide; α4β1 integrin activator.
NSAID; NMDA inverse agonist, T-type Ca2+ and Cl...
NSAID; COX-1/2 and PDE inhibitor.